Progression-Free but No Overall Survival Benefit for Adult Patients with Bevacizumab Therapy for the Treatment of Newly Diagnosed Glioblastoma: A Systematic Review and Meta-Analysis

Glioblastoma (GBM) is the most common high-grade primary brain tumor in adults. Standard multi-modality treatment of glioblastoma with surgery, temozolomide chemotherapy, and radiation results in transient tumor control but inevitably gives way to disease progression. The need for additional therape...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaka, Nagham, Hafazalla, Karim, Samawi, Haider, Simpkin, Andrew, Perry, James, Sahgal, Arjun, Das, Sunit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895972/
https://www.ncbi.nlm.nih.gov/pubmed/31689995
http://dx.doi.org/10.3390/cancers11111723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895972/
https://www.ncbi.nlm.nih.gov/pubmed/31689995
http://dx.doi.org/10.3390/cancers11111723

Ejemplares similares